|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
4 September 2023 |
|
Main ID: |
NCT02316392 |
|
Date of registration:
|
10/12/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Imaging and Understanding BOS in Lung Transplantation
|
|
Scientific title:
|
Imaging and Understanding BOS in Lung Transplantation |
|
Date of first enrolment:
|
December 2014 |
|
Target sample size:
|
6 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02316392 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Jason Woods, PhD. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Cincinnati Children's |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Lung Transplantation within the last 10 years or being assessed for possible lung
transplantation.
- Male or female
- 0 to 25 years of age.
Exclusion Criteria:
- Standard MRI exclusion criteria as set forth by the CCHMC Division of Radiology
- Inability to perform 10 second breath hold for 3He MRI scan
- Bleeding disorders
Age minimum:
1 Year
Age maximum:
25 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Bronchiolitis Obliterans Syndrome
|
|
Intervention(s)
|
|
Drug: Hyperpolarized Helium-3 MRI
|
|
Primary Outcome(s)
|
|
Analysis of MRI imaging to detect BOS compared to biopsy
[Time Frame: 3 years]
|
|
Secondary ID(s)
|
|
2014-6004
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|